NFκB Inhibitor 억제제 CAS: 213546-53-3
MW: 2781.5
Inhibits translocation of the NFκB active complex into the nucleus.

NFκB Inhibitor 억제제 (CAS 213546-53-3)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 103ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
NFκB Inhibitor 억제제 is rated 5.0 out of 5 by 2.
loading
5
2
4
0
3
0
2
0
1
0
Alternate Names: NF-κB SN50 cell permeable inhibitory peptide; AAVALLPAVLLALLAPVQRKRQKLMP
Application NFκB Inhibitor is inhibits translocation of the NFκB active complex into the nucleus
CAS 등록번호: 213546-53-3
순도: ≥97%
분자량: 2781.5
연구용으로만 사용가능합니다. 진단이나 치료용으로 사용불가합니다.
* 참조분석증명서대량의 측정 데이터(함수량포함).
loading

NFκB Inhibitor is a synthetic inhibitor for NFκB. This inhibitor contains Noxious Liquid Substance (NLS) residues 360-369 of NFκB p50. This inhibits translocation of the NFκB active complex into the nucleus.

Appearance :
Lyophilized
Physical State :
Solid
시퀀스 :
H-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Val-Gln-Arg-Lys-Arg-Gln-Lys-Leu-Met-Pro-OH
용해도 :
Soluble in water or ethanol (50% or 100%).
저장 :
Store at -20° C
연구용으로만 사용가능합니다. 진단이나 치료용으로 사용불가합니다.

SDS(MSDS)다운로드

분석증명서

PDF문서를 열람,
프린트와 코멘트를 작성하려면 Adobe Acrobat Reader가 필요합니다.

NFκB Inhibitor 억제제 (CAS 213546-53-3)  논문정보

다른 사용자의 NFκB Inhibitor 억제제 (CAS 213546-53-3)사용법보기. 클릭하여 PubMed entry보기 .

인용 1 to 10 of 63 합계

PMID: # 34004182  Borkar, NA.|Roos, B.|Prakash, YS.|Sathish, V.|Pabelick, CM.| et al. 2021. Arch Biochem Biophys. 108897.

PMID: # 34209215  Dorandish, S.|Atali, S.|Ray, R.|Al Khashali, H.|Coleman, KL.|Guthrie, J.|Heyl, D.|Evans, HG.| et al. 2021. Int J Mol Sci. 22:

PMID: # 33820561  Chen, Y.|Tian, Z.|He, L.|Liu, C.|Wang, N.|Rong, L.|Liu, B.| et al. 2021. Stem Cell Res Ther. 12: 224.

PMID: # 33958632  Dorandish, S.|Williams, A.|Atali, S.|Sendo, S.|Price, D.|Thompson, C.|Guthrie, J.|Heyl, D.|Evans, HG.| et al. 2021. Sci Rep. 11: 9708.

PMID: # 34299155  Ouyang, W.|Xie, T.|Fang, H.|Gao, C.|Stantchev, T.|Clouse, KA.|Yuan, K.|Ju, T.|Frucht, DM.| et al. 2021. Int J Mol Sci. 22:

PMID: # 31239273  Acharya, S.|Yao, J.|Li, P.|Zhang, C.|Lowery, FJ.|Zhang, Q.|Guo, H.|Qu, J.|Yang, F.|Wistuba, II.|Piwnica-Worms, H.|Sahin, AA.|Yu, D.| et al. 2019. Cancer Res.

PMID: # 31178956  Helfinger, V.|Palfi, K.|Weigert, A.|Schröder, K.| et al. 2019. Oxid Med Cell Longev. 2019: 3264858.

PMID: # 29540860  2018. Lab. Invest. 98: 708-714.

PMID: # 30155724  Malik, DE.|David, RM.|Gooderham, NJ.| et al. 2018. Arch. Toxicol. 92: 3223-3239.

PMID: # 28739828  Naik, SK.|Padhi, A.|Ganguli, G.|Sengupta, S.|Pati, S.|Das, D.|Sonawane, A.| et al. 2017. Infect. Immun. 85:

인용 1 to 10 of 63 합계
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 115ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 8ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;